Published in J Otolaryngol Head Neck Surg on June 01, 2009
Long-term quality of life and its predictive factors after oncologic surgery and microvascular reconstruction in patients with oral or oropharyngeal cancer. Eur Arch Otorhinolaryngol (2013) 0.89
Autonomous reparative unit (ARU): a new concept of repairing free flap donor site with local full-thickness skin graft. Acta Otorhinolaryngol Ital (2010) 0.83
Impact of patient comorbidities on head and neck microvascular reconstruction. A report on 423 cases. Eur Arch Otorhinolaryngol (2012) 0.77
Outcome and prognostic factors in T4a oropharyngeal carcinoma, including the role of HPV infection. Biomed Res Int (2014) 0.75
The development of an ICF-based clinical guideline and screening tool for the standardized assessment and evaluation of functioning after head and neck cancer treatment. Eur Arch Otorhinolaryngol (2016) 0.75
Bevacizumab combined with chemotherapy for platinum-resistant recurrent ovarian cancer: The AURELIA open-label randomized phase III trial. J Clin Oncol (2014) 6.28
Phase II trial of weekly paclitaxel for unresectable angiosarcoma: the ANGIOTAX Study. J Clin Oncol (2008) 2.85
Randomized trial of postoperative reirradiation combined with chemotherapy after salvage surgery compared with salvage surgery alone in head and neck carcinoma. J Clin Oncol (2008) 2.03
HIF-1alpha and CA IX staining in invasive breast carcinomas: prognosis and treatment outcome. Int J Cancer (2007) 1.86
Clinical practice guidelines for the prevention and treatment of EGFR inhibitor-associated dermatologic toxicities. Support Care Cancer (2011) 1.78
In vivo measurements with MOSFET detectors in oropharynx and nasopharynx intensity-modulated radiation therapy. Int J Radiat Oncol Biol Phys (2005) 1.78
Multi institutional phase II study of concomitant stereotactic reirradiation and cetuximab for recurrent head and neck cancer. Radiother Oncol (2013) 1.68
Docetaxel and gemcitabine combination in 133 advanced soft-tissue sarcomas: a retrospective analysis. Int J Cancer (2006) 1.65
Stereotactic ablative radiotherapy for pulmonary oligometastases and oligometastatic lung cancer. J Thorac Oncol (2014) 1.51
Bilateral breast involvement in medullary thyroid carcinoma. Thyroid (2009) 1.50
Influence of internal mammary node irradiation on long-term outcome and contralateral breast cancer incidence in node-negative breast cancer patients. Radiother Oncol (2013) 1.49
Immunoglobulin heavy chain/light chain pair measurement is associated with survival in diffuse large B-cell lymphoma. Leuk Lymphoma (2013) 1.49
Percutaneous screw fixation of acetabular roof fractures by radiologists under CT and fluoroscopy guidance. AJR Am J Roentgenol (2013) 1.44
Impact of intensity-modulated radiotherapy on health-related quality of life for head and neck cancer patients: matched-pair comparison with conventional radiotherapy. Int J Radiat Oncol Biol Phys (2007) 1.43
Myositis ossificans imaging: keys to successful diagnosis. Indian J Radiol Imaging (2012) 1.36
Oral complications of cancer and cancer therapy: from cancer treatment to survivorship. CA Cancer J Clin (2012) 1.30
Event-free survival at 24 months is a robust end point for disease-related outcome in diffuse large B-cell lymphoma treated with immunochemotherapy. J Clin Oncol (2014) 1.26
Prognostic value of tumoral thymidylate synthase and p53 in metastatic colorectal cancer patients receiving fluorouracil-based chemotherapy: phenotypic and genotypic analyses. J Clin Oncol (2002) 1.19
French multicenter phase III randomized study testing concurrent twice-a-day radiotherapy and cisplatin/5-fluorouracil chemotherapy (BiRCF) in unresectable pharyngeal carcinoma: Results at 2 years (FNCLCC-GORTEC). Int J Radiat Oncol Biol Phys (2006) 1.13
Intensity-modulated radiotherapy in head and neck cancer: results of the prospective study GORTEC 2004-03. Radiother Oncol (2012) 1.10
Clinical practice guidelines for the prevention and treatment of acute and late radiation reactions from the MASCC Skin Toxicity Study Group. Support Care Cancer (2013) 1.10
Criteria to choose between distal or proximal venous port device insertion in HNC patients. Cardiovasc Intervent Radiol (2012) 1.10
The role of neck dissection in the setting of chemoradiation therapy for head and neck squamous cell carcinoma with advanced neck disease. Oral Oncol (2011) 1.09
Atlas-based automatic segmentation of MR images: validation study on the brainstem in radiotherapy context. Int J Radiat Oncol Biol Phys (2005) 1.09
Insights into digital tomosynthesis of interstitial lung disease. Radiographics (2014) 1.09
Early-stage primary bone lymphoma: a retrospective, multicenter Rare Cancer Network (RCN) Study. Int J Radiat Oncol Biol Phys (2011) 1.07
Three-tiered system for incidental thyroid nodules: do not forget the calcifications. AJR Am J Roentgenol (2014) 1.06
Head and neck squamous cell carcinoma in patients aged > or = 80 years: patterns of care and survival. Cancer (2008) 1.03
A synonymous polymorphism of the Tristetraprolin (TTP) gene, an AU-rich mRNA-binding protein, affects translation efficiency and response to Herceptin treatment in breast cancer patients. Hum Mol Genet (2011) 1.02
[Standards, options and recommendations for nutritional support in bone marrow transplant patients]. Bull Cancer (2002) 1.01
The CXCL7/CXCR1/2 axis is a key driver in the growth of clear cell renal cell carcinoma. Cancer Res (2013) 1.01
Modeling of salivary production recovery after radiotherapy using mixed models: determination of optimal dose constraint for IMRT planning and construction of convenient tools to predict salivary function. Int J Radiat Oncol Biol Phys (2008) 1.00
Prognostic impact of the epidermal growth factor receptor levels for patients with larynx and hypopharynx cancer. Oral Oncol (2005) 1.00
Postoperative radiotherapy in head and neck mucosal melanoma: a GETTEC study. Arch Otolaryngol Head Neck Surg (2010) 1.00
Free-flap head and neck reconstruction and quality of life: a 2-year prospective study. Laryngoscope (2008) 0.99
Anal canal cancer: management of inguinal nodes and benefit of prophylactic inguinal irradiation (CORS-03 Study). Int J Radiat Oncol Biol Phys (2011) 0.98
Diplopia as the first symptom of an aggressive metastatic rectal stromal tumor. Onkologie (2009) 0.96
Biocomputing: numerical simulation of glioblastoma growth using diffusion tensor imaging. Phys Med Biol (2008) 0.95
Cetuximab shows activity in colorectal cancer patients with tumors for which FISH analysis does not detect an increase in EGFR gene copy number. Ann Surg Oncol (2007) 0.95
Venous obstruction of thyroid malignancy origin: the Antoine Lacassagne Institute experience. World J Surg Oncol (2009) 0.94
Extraskeletal Osteosarcoma: An International Rare Cancer Network Study. Am J Clin Oncol (2016) 0.93
Randomised, multi-centre study of the usefulness of the heat and moisture exchanger (Provox HME®) in laryngectomised patients. Eur Arch Otorhinolaryngol (2011) 0.93
Symptomatic lumbar facet joint cysts treated by CT-guided intracystic and intra-articular steroid injections. Eur Radiol (2012) 0.92
Is routine triple endoscopy for head and neck carcinoma patients necessary in light of a negative chest computed tomography scan? Cancer (2004) 0.92
Phase II trial evaluating a docetaxel-capecitabine combination as treatment for hormone-refractory prostate cancer. Cancer (2006) 0.92
Influence of the VEGF-A 936C>T germinal polymorphism on tumoral VEGF expression in head and neck cancer. Pharmacogenomics (2009) 0.92
Results of vocal rehabilitation using tracheoesophageal voice prosthesis after total laryngectomy and their predictive factors. Eur Arch Otorhinolaryngol (2009) 0.92